Literature DB >> 26550114

Up-regulation of miR-506 inhibits cell growth and disrupt the cell cycle by targeting YAP in breast cancer cells.

Kaiyao Hua1, Weiguo Yang2, Hongming Song1, Jialu Song1, Chuankui Wei1, Dengfeng Li1, Lin Fang1.   

Abstract

MicroRNAs (miRNAs) are a small class of non-coding RNAs that are extensively deregulated in various cancers. They can act as either oncogenes or tumor suppressor genes in human cancer. The purpose of this study was to investigate the crucial role of miR-506 in breast cancer and to validate whether miR-506 could regulate proliferation of breast cancer cells by targeting YAP (Yes-associated protein) gene. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to quantify the expression levels of miR-506 in breast cancer and adjacent non-cancerous breast tissues. To characterize the miR-506 function, MTT assays, colony formation assays, cell migration assays, cell invasion assays and cell cycle assays were used. Finally, luciferase reporter assays were performed to validate the regulation of a putative target of miR-506, in corroboration with western blot assays. We found that expression of miR-506 was commonly down-regulated in breast cancer cells and breast cancer specimens when compared with that in non-malignant breast epithelial cells and adjacent normal tissues. Up-regulation of miR-506 inhibited cellular proliferation, migration and invasion as well as disrupt the cell cycle of breast cancer cells. Luciferase assays revealed that miR-506 directly bound to the 3'-untranslated region (3'-UTR) of YAP. Western blot analysis verified that miR-506 regulated the expression of YAP at the protein levels. These findings suggest that miR-506 exerts as a tumor suppressor in breast cancer and up-regulation of miR-506 expression inhibits cellular growth, cell migration and invasion as well as disrupt the cell cycle by targeting YAP. Our study demonstrates that the miR-506/YAP axis may help us better understand the molecular mechanisms of breast cancer progression.

Entities:  

Keywords:  MiR-506; YAP; breast cancer

Year:  2015        PMID: 26550114      PMCID: PMC4612799     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.

Authors:  Richard I Gregory; Thimmaiah P Chendrimada; Neil Cooch; Ramin Shiekhattar
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

3.  MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1.

Authors:  Jun Deng; Wan Lei; Xiaojun Xiang; Ling Zhang; Feng Yu; Jun Chen; Miao Feng; Jianping Xiong
Journal:  Tumour Biol       Date:  2015-04-07

4.  The role of miR-506 in transformed 16HBE cells induced by anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide.

Authors:  Yao Zhao; Huanying Liu; Yuanqi Li; Jianjun Wu; Anne R Greenlee; Chengfeng Yang; Yiguo Jiang
Journal:  Toxicol Lett       Date:  2011-06-24       Impact factor: 4.372

5.  Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer.

Authors:  Xiaodan Wang; Lili Su; Qishui Ou
Journal:  Eur J Cancer       Date:  2011-11-05       Impact factor: 9.162

6.  miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer.

Authors:  S-Y Wen; Y Lin; Y-Q Yu; S-J Cao; R Zhang; X-M Yang; J Li; Y-L Zhang; Y-H Wang; M-Z Ma; W-W Sun; X-L Lou; J-H Wang; Y-C Teng; Z-G Zhang
Journal:  Oncogene       Date:  2014-03-10       Impact factor: 9.867

7.  The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.

Authors:  John M Lamar; Patrick Stern; Hui Liu; Jeffrey W Schindler; Zhi-Gang Jiang; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

Review 8.  Genetic variation in microRNA networks: the implications for cancer research.

Authors:  Bríd M Ryan; Ana I Robles; Curtis C Harris
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

9.  YAP1 increases organ size and expands undifferentiated progenitor cells.

Authors:  Fernando D Camargo; Sumita Gokhale; Jonathan B Johnnidis; Dongdong Fu; George W Bell; Rudolf Jaenisch; Thijn R Brummelkamp
Journal:  Curr Biol       Date:  2007-11-01       Impact factor: 10.834

10.  miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines.

Authors:  Himanshu Arora; Rehana Qureshi; Woong-Yang Park
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more
  8 in total

1.  [YAP1 knockdown suppresses the proliferation, migration and invasion of human nasopharyngeal carcinoma cells].

Authors:  Yaqing Zhou; Rong Yang; Gang Ma
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-03-30

2.  The Hippo Transducer YAP/TAZ as a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients.

Authors:  Jia-Qi Yuan; Nian-Hua Ding; Zhi Xiao
Journal:  Front Pharmacol       Date:  2020-08-27       Impact factor: 5.810

3.  MicroRNA‑506 regulates apoptosis in retinoblastoma cells by targeting sirtuin 1.

Authors:  Zhidu Song; Hailiang Wang; Fangwei Zong; Chao Zhu; Ying Tao
Journal:  Cancer Manag Res       Date:  2019-09-16       Impact factor: 3.989

Review 4.  Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer.

Authors:  Qinqin Li; Zhenghuan Rao; Yanlin Wang; Lei Zhang; Jing Chen; Runlan Wan; Alexander Tobias Teichmann
Journal:  Cancer Cell Int       Date:  2021-06-10       Impact factor: 5.722

Review 5.  The emerging role of miR-506 in cancer.

Authors:  Jian Li; Jingfang Ju; Bing Ni; Huaizhi Wang
Journal:  Oncotarget       Date:  2016-09-20

6.  Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse.

Authors:  Matthieu Corvaisier; Marjolaine Bauzone; François Corfiotti; Florence Renaud; Mehdi El Amrani; Didier Monté; Stéphanie Truant; Emmanuelle Leteurtre; Pierre Formstecher; Isabelle Van Seuningen; Christian Gespach; Guillemette Huet
Journal:  Oncotarget       Date:  2016-08-30

Review 7.  Multifaceted regulation and functions of YAP/TAZ in tumors (Review).

Authors:  Huirong Liu; Suya Du; Tiantian Lei; Hailian Wang; Xia He; Rongsheng Tong; Yi Wang
Journal:  Oncol Rep       Date:  2018-05-08       Impact factor: 3.906

8.  circPCNX and Pecanex Promote Hepatocellular Carcinoma Cell Viability by Inhibiting miR-506.

Authors:  Peng Sun; Xinyi Fan; Xiao Hu; Xiaoyue Fu; Qian Wei; Yunjin Zang
Journal:  Cancer Manag Res       Date:  2019-12-31       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.